Education and Training
- Ph.D., University of California at Davis, 2004
Townsley, Samantha, Zeinab Mohamed, Wenjin Guo, Jennifer McKenna, Brad Cleveland, Celia LaBranche, David Beaumont, et al. “Induction of Heterologous Tier 2 HIV-1-Neutralizing and Cross-Reactive V1/V2-Specific Antibodies in Rabbits by Prime-Boost Immunization..” Journal of Virology 90, no. 19 (October 2016): 8644–60. https://doi.org/10.1128/JVI.00853-16.
Iyer, Smita S., Sailaja Gangadhara, Blandine Victor, Xiaoying Shen, Xuemin Chen, Rafiq Nabi, Sudhir P. Kasturi, et al. “Virus-Like Particles Displaying Trimeric Simian Immunodeficiency Virus (SIV) Envelope gp160 Enhance the Breadth of DNA/Modified Vaccinia Virus Ankara SIV Vaccine-Induced Antibody Responses in Rhesus Macaques..” Journal of Virology 90, no. 19 (October 2016): 8842–54. https://doi.org/10.1128/JVI.01163-16.
Gordon, Shari N., Namal P. M. Liyanage, Melvin N. Doster, Monica Vaccari, Diego A. Vargas-Inchaustegui, Poonam Pegu, Luca Schifanella, et al. “Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIVmac251 Acquisition..” Journal of Immunology (Baltimore, Md. : 1950) 197, no. 7 (October 2016): 2726–37. https://doi.org/10.4049/jimmunol.1600674.
Andersson, Anne-Marie C., Emeline Ragonnaud, Kelly E. Seaton, Sheetal Sawant, Antonella Folgori, Stefano Colloca, Celia Labranche, David C. Montefiori, Georgia D. Tomaras, and Peter J. Holst. “Effect of HIV-1 envelope cytoplasmic tail on adenovirus primed virus encoded virus-like particle immunizations..” Vaccine 34, no. 44 (October 2016): 5344–51. https://doi.org/10.1016/j.vaccine.2016.08.089.
Vaccari, Monica, Shari N. Gordon, Slim Fourati, Luca Schifanella, Namal P. M. Liyanage, Mark Cameron, Brandon F. Keele, et al. “Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition..” Nature Medicine 22, no. 10 (October 2016). https://doi.org/10.1038/nm1016-1192a.
Abdulhaqq, S. A., C. Zorrilla, G. Kang, X. Yin, V. Tamayo, K. E. Seaton, J. Joseph, et al. “HIV-1-negative female sex workers sustain high cervical IFNɛ, low immune activation, and low expression of HIV-1-required host genes..” Mucosal Immunology 9, no. 4 (July 2016): 1027–38. https://doi.org/10.1038/mi.2015.116.
Vaccari, Monica, Shari N. Gordon, Slim Fourati, Luca Schifanella, Namal P. M. Liyanage, Mark Cameron, Brandon F. Keele, et al. “Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition..” Nature Medicine 22, no. 7 (July 2016): 762–70. https://doi.org/10.1038/nm.4105.
Gray, Glenda E., Kenneth H. Mayer, Marnie L. Elizaga, Linda-Gail Bekker, Mary Allen, Lynn Morris, David Montefiori, et al. “Subtype C gp140 Vaccine Boosts Immune Responses Primed by the South African AIDS Vaccine Initiative DNA-C2 and MVA-C HIV Vaccines after More than a 2-Year Gap..” Clinical and Vaccine Immunology : Cvi 23, no. 6 (June 6, 2016): 496–506. https://doi.org/10.1128/CVI.00717-15.
O’Connell, Robert J., Jean-Louis Excler, Victoria R. Polonis, Silvia Ratto-Kim, Josephine Cox, Linda L. Jagodzinski, Michelle Liu, et al. “Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene..” The Journal of Infectious Diseases 213, no. 12 (June 2016): 1946–54. https://doi.org/10.1093/infdis/jiw059.
Le Grand, Roger, Nathalie Dereuddre-Bosquet, Stefania Dispinseri, Leslie Gosse, Delphine Desjardins, Xiaoying Shen, Monica Tolazzi, et al. “Superior Efficacy of a Human Immunodeficiency Virus Vaccine Combined with Antiretroviral Prevention in Simian-Human Immunodeficiency Virus-Challenged Nonhuman Primates..” Journal of Virology 90, no. 11 (June 2016): 5315–28. https://doi.org/10.1128/JVI.00230-16.